Quarterly Earnings

Amid market headwinds, JD.com cancels $3B in shares to boost value, signaling deep confidence while juggling costly strategic growth initiatives.

Sana Biotechnology prepares for its pivotal J.P. Morgan update, balancing groundbreaking diabetes data against a ticking financial clock and fierce competition.

Asure Software appoints veteran COO Mike Eralie to scale operations, signaling a strategic push to enhance client experience in the competitive HCM market.

As legacy brand Hamilton Beach heads to a major conference, its high-stakes pivot from kitchen gadgets to health tech will be under the microscope.

With a major acquisition and a volatile stock, all eyes are on ServiceNow's Jan 28 results to prove its AI strategy is delivering real financial growth.

The San Diego-based credit union is partnering with the AI lending giant to expand loan access, signaling a major shift in how local finance competes.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

NRG Energy names insider Robert J. Gaudette as its next CEO, signaling strategic continuity as the energy giant navigates a market in transformation.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

Apogee Enterprises taps a veteran insider as interim CFO after Matthew Osberg's exit coincides with a sharp stock drop and reduced financial guidance.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

As Radware preps its 2025 results, investors watch to see if its AI-driven strategy can sustain growth and outpace rivals in a booming cybersecurity market.

Alerus Financial is set to release its Q4 results, capping a year of strategic growth. Investors watch to see if its unique model can sustain momentum.

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Array Technologies promotes two key executives, signaling an aggressive strategy to boost global revenue and product innovation in the booming solar tracker market.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

Newcomer Candid Therapeutics is set to unveil its T-cell engager platform at J.P. Morgan, a move that could shake up the autoimmune treatment landscape.

While US sales numbers declined in 2025, Mazda posted record CPO figures, earned top safety honors, and saw major growth in Canada and Mexico.